Magnetic resonance imaging in Alzheimer's Disease Neuroimaging Initiative 2

被引：141

作者：

Jack, Clifford R., Jr. ^{[1
]}

Barnes, Josephine ^{[2
]}

Bernstein, Matt A. ^{[1
]}

Borowski, Bret J. ^{[1
]}

Brewer, James ^{[3
]}

Clegg, Shona ^{[2
]}

Dale, Anders M. ^{[3
]}

Carmichael, Owen ^{[4
]}

Ching, Christopher ^{[5
]}

DeCarli, Charles ^{[4
,6
]}

Desikan, Rahul S. ^{[7
]}

Fennema-Notestine, Christine ^{[7
,8
]}

Fjell, Anders M. ^{[9
]}

Fletcher, Evan ^{[4
,6
]}

Fox, Nick C. ^{[2
]}

Gunter, Jeff ^{[1
]}

Gutman, Boris A. ^{[3
]}

Holland, Dominic ^{[3
]}

Hua, Xue ^{[3
]}

Insel, Philip ^{[10
]}

Kantarci, Kejal ^{[1
]}

Killiany, Ron J. ^{[11
]}

Krueger, Gunnar ^{[12
]}

Leung, Kelvin K. ^{[13
]}

Mackin, Scott ^{[10
,14
]}

Maillard, Pauline ^{[4
,6
]}

Malone, Ian B. ^{[2
]}

Mattsson, Niklas ^{[15
]}

McEvoy, Linda ^{[7
]}

Modat, Marc ^{[2
,13
]}

Mueller, Susanne ^{[10
,16
]}

Nosheny, Rachel ^{[10
,16
]}

Ourselin, Sebastien ^{[2
,13
]}

Schuff, Norbert ^{[10
,16
]}

Senjem, Matthew L. ^{[1
]}

Simonson, Alix ^{[10
]}

Thompson, Paul M. ^{[5
]}

Rettmann, Dan ^{[17
]}

Vemuri, Prashanthi ^{[1
]}

Walhovd, Kristine ^{[9
]}

Zhao, Yansong ^{[18
]}

Zuk, Samantha ^{[1
]}

Weiner, Michael ^{[10
,14
,16
,19
,20
]}

机构：

[1] Mayo Clin, Dept Radiol, Rochester, MN 55905 USA

[2] UCL, Dementia Res Ctr, Inst Neurol, Dept Neurodegenerat Dis, London, England

[3] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA

[4] Univ Calif Davis, Dept Neurol, Davis, CA 95616 USA

[5] Univ So Calif, Imaging Genet Ctr, Inst Neuroimaging & Informat, Dept Neurol, Marina Del Rey, CA USA

[6] Univ Calif Davis, Ctr Neurosci, Davis, CA 95616 USA

[7] Univ Calif San Diego, Dept Radiol, La Jolla, CA 92093 USA

[8] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA

[9] Univ Oslo, Dept Psychol, Oslo, Norway

[10] San Francisco VA Med Ctr, Ctr Imaging Neurodegenerat Dis, Dept Radiol & Biomed Imaging, San Francisco, CA USA

[11] Boston Univ, Sch Med, Dept Anat & Neurobiol, Boston, MA 02118 USA

[12] Siemens Med Solut, Boston, MA USA

[13] UCL, Ctr Med Image Comp, Translat Imaging Grp, London, England

[14] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA USA

[15] Univ Gothenburg, Inst Neurosci & Physiol, Clin Neurochem Lab, Molndal, Sweden

[16] Univ Calif San Francisco, Dept Radiol, San Francisco, CA 94143 USA

[17] GE Healthcare, MR Applicat & Workflow, Rochester, MN USA

[18] Philips Healthcare, Cleveland, OH USA

[19] Univ Calif San Francisco, Dept Med, San Francisco, CA USA

[20] Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA

来源：

ALZHEIMERS & DEMENTIA | 2015年 / 11卷 / 07期

关键词：

Alzheimer's disease; Alzheimer's Disease Neuroimaging Initiative; ADNI; Diffusion; MRI; Neuroimaging; Perfusion; Resting functional MRI; MILD COGNITIVE IMPAIRMENT; BRAIN AMYLOID-BETA; NATIONAL INSTITUTE; CSF BIOMARKERS; ASSOCIATION WORKGROUPS; DIAGNOSTIC GUIDELINES; ATROPHY RATE; HIPPOCAMPAL ATROPHY; HYPOTHETICAL MODEL; NETWORK MEASURES;

D O I：

10.1016/j.jalz.2015.05.002

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

Introduction: Alzheimer's Disease Neuroimaging Initiative (ADNI) is now in its 10th year. The primary objective of the magnetic resonance imaging (MRI) core of ADNI has been to improve methods for clinical trials in Alzheimer's disease (AD) and related disorders. Methods: We review the contributions of the MRI core from present and past cycles of ADNI (ADNI-1, -Grand Opportunity and -2). We also review plans for the future-ADNI-3. Results: Contributions of the MRI core include creating standardized acquisition protocols and quality control methods; examining the effect of technical features of image acquisition and analysis on outcome metrics; deriving sample size estimates for future trials based on those outcomes; and piloting the potential utility of MR perfusion, diffusion, and functional connectivity measures in multicenter clinical trials. Discussion: Over the past decade the MRI core of ADNI has fulfilled its mandate of improving methods for clinical trials in AD and will continue to do so in the future. (C) 2015 The Authors. Published by Elsevier Inc. on behalf of the Alzheimer's Association.

引用

页码：740 / 756

页数：17

共 50 条

[41] Magnetic resonance imaging relaxation time in Alzheimer's disease
Tang, Xiang
Cai, Feng
Ding, Dong-Xue
Zhang, Lu-Lu
Cai, Xiu-Ying
Fang, Qi
BRAIN RESEARCH BULLETIN, 2018, 140 : 176 - 189
[42] Advances in perfusion magnetic resonance imaging in Alzheimer's disease
Chen, Wei
Song, Xiaowei
Beyea, Steven
D'Arcy, Ryan
Zhang, Yunting
Rockwood, Kenneth
ALZHEIMERS & DEMENTIA, 2011, 7 (02) : 185 - 196
[43] Magnetic-resonance imaging to assess Alzheimer's disease
Skoog, I
LANCET, 2002, 359 (9317): : 1538 - 1539
[44] Research on magnetic resonance imaging in diagnosis of Alzheimer's disease
Zhao, Guohua
Zhang, Haixia
Xu, Yuzhen
Chu, Xiuli
EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2024, 29 (01)
[45] Magnetic resonance imaging and computed tomography in Alzheimer's disease
Wahlund, LO
ACTA NEUROLOGICA SCANDINAVICA, 1996, 94 : 50 - 53
[46] Changes in Brain Lateralization in Patients with Mild Cognitive Impairment and Alzheimer's Disease: A Resting-State Functional Magnetic Resonance Study from Alzheimer's Disease Neuroimaging Initiative
Liu, Hao
Zhang, Lele
Xi, Qian
Zhao, Xiaohu
Wang, Fei
Wang, Xiangbin
Men, Weiwei
Lin, Qixiang
FRONTIERS IN NEUROLOGY, 2018, 9
[47] Addressing population aging and Alzheimer's disease through the Australian Imaging Biomarkers and Lifestyle study: Collaboration with the Alzheimer's Disease Neuroimaging Initiative
Ellis, Kathryn A.
Rowe, Christopher C.
Villemagne, Victor L.
Martins, Ralph N.
Masters, Colin L.
Salvado, Olivier
Szoeke, Cassandra
Ames, David
ALZHEIMERS & DEMENTIA, 2010, 6 (03) : 291 - 296
[48] The longitudinal trajectory of CSF sTREM2: the alzheimer's disease neuroimaging initiative
Wang, Yu
Ye, Meijie
Ji, Qianqian
Liu, Qi
Xu, Xiaowei
Zhan, Yiqiang
ALZHEIMERS RESEARCH & THERAPY, 2024, 16 (01)
[49] The Alzheimer's Disease Neuroimaging Initiative 2 Biomarker Core: A review of progress and plans
Kang, Ju-Hee
Korecka, Magdalena
Figurski, Michal J.
Toledo, Jon B.
Blennow, Kaj
Zetterberg, Henrik
Waligorska, Teresa
Brylska, Magdalena
Fields, Leona
Shah, Nirali
Soares, Holly
Dean, Robert A.
Vanderstichele, Hugo
Petersen, Ronald C.
Aisen, Paul S.
Saykin, Andrew J.
Weiner, Michael W.
Trojanowski, John Q.
Shaw, Leslie M.
ALZHEIMERS & DEMENTIA, 2015, 11 (07) : 772 - 791
[50] Empirically defining the preclinical stages of the Alzheimer's continuum in the Alzheimer's Disease Neuroimaging Initiative
Kiselica, Andrew M.
PSYCHOGERIATRICS, 2021, 21 (04) : 491 - 502

← 1 2 3 4 5 →